Prevention of Gastrointestinal Toxicity From Total Body Irradiation or High Dose Chemotherapy With Pasireotide
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Pasireotide (Primary) ; Busulfan; Methotrexate
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2015 Planned End Date changed from 1 Oct 2020 to 1 Jan 2020, according to ClinicalTrials.gov record.
- 17 Feb 2015 Planned primary completion date changed from 1 Oct 2018 to 1 Jan 2019, according to ClinicalTrials.gov record.